Abstract
Osteoporosis and sarcopenia are the most frequent musculoskeletal disorders affecting older people. Osteoporosis is a widespread disorder affecting millions of individuals of all ethnic backgrounds worldwide, particularly among older women. It is characterized by reduced bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in the risk of fracture. Sarcopenia is considered to be one of the major factors responsible for functional limitations and motor dependency in elderly persons. In age-related muscle atrophy, a decrease in muscle fiber size and number, and a preferential loss of type II fibers have been reported. A decrease in the circulating levels of specific hormones (e.g., estrogen, testosterone, growth hormone, and insulin-like growth factor-1) has been shown to be associated with sarcopenia and this appears to play an important role in its pathogenesis.
References
Heuberger RA (2011) The frailty syndrome: a comprehensive review J Nutr Gerontol Geriatr 30(4):315–368
Cooper C, Dere W, Evans W et al (2012) Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int 23(7):1839–1848
Clegg A, Young J, Iliffe S et al (2013) Frailty in elderly people Lancet 381(9868):752–762
Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156
Rolland Y, Czerwinski S, Abellan Van Kan G et al (2008) Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 12(7):433–450
Sumnik Z, Land C, Coburger S et al (2006) The muscle-bone unit in adulthood: influence of sex, height, age and gynecological history on the bone mineral content and muscle cross-sectional area. J Musculoskelet Neuronal Interact 6(2):195–200
Frontera WR, Zayas AR, Rodriguez N (2012) Aging of human muscle: understanding sarcopenia at the single muscle cell level. Phys Med Rehabil Clin N Am 23(1):201–207
Frost HM (1999) Why do bone strength and “mass” in aging adults become unresponsive to vigorous exercise? Insights of the Utah paradigm. J Bone Miner Metab 17(2):90–97
Fielding RA, Vellas B, Evans WJ, et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12(4):249–256
Messier V, Rabasa-Lhoret R, Barbat-Artigas S et al (2011) Menopause and sarcopenia: a potential role for sex hormones. Maturitas 68(4):331–336
Seeman E (2002) Pathogenesis of bone fragility in women and men. Lancet 359(9320):1841–1850
Lexell J, Henriksson-Larsén K, Winblad B et al (1983) Distribution of different fiber types in human skeletal muscles: effects of aging studied in whole muscle cross sections. Muscle Nerve 6(8):588–595
Faulkner JA, Larkin LM, Claflin DR, Brooks SV (2007) Age-related changes in the structure and function of skeletal muscles. Clin Exp Pharmacol Physiol 34(11):1091–1096
Izquierdo M, Ibáñez J, Häkkinen K et al (2004) Maximal strength and power, muscle mass, endurance and serum hormones in weightlifters and road cyclists. J Sports Sci 22(5):465–478
Deschenes MR (2004) Effects of aging on muscle fibre type and size. Sports Med 34(12):809–824
Bouxsein ML (2003) Bone quality: where do we go from here? Osteoporos Int 14(Suppl 5):S118–S127
Schakman O, Gilson H, Thissen JP (2008) Mechanisms of glucocorticoid-induced myopathy. Endocrinology 197:1–10
Morley JE, Thomas DR, Wilson MM (2006) Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83:735–743
Sun Z, Liu L, Liu N, Liu Y (2008) Muscular response and adaptation to diabetes mellitus. Front Biosci 13:4765–4794
Perrini S, Laviola L, Carreira MC et al (2010) The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol 205:201–210
Glass DJ (2010) Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care 13:225–229
Terracciano C, Celi M, Lecce D et al (2013) Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis. Osteoporos Int 24(3):1095–1100
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tarantino, U., Baldi, J., Celi, M. et al. Osteoporosis and sarcopenia: the connections. Aging Clin Exp Res 25 (Suppl 1), 93–95 (2013). https://doi.org/10.1007/s40520-013-0097-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-013-0097-7